An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide and devotes between 20% and 25% of its revenues to R&D.
Looking for a particular Provepharm employee's phone or email?
The Provepharm annual revenue was $34.2 million in 2026.
Rob Sterling is the VP, Business Development and Licensing, and Operations of Provepharm.
94 people are employed at Provepharm.
Provepharm is based in Marseille, Provence-Alpes-Cote d'Azur.
The NAICS codes for Provepharm are [3254, 32, 32541, 325, 456, 45].
The SIC codes for Provepharm are [283, 28].